blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1449536

EP1449536 - Prion proteins (PrP) as therapeutic agents for the treatment of AP-1 associated diseases [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  14.07.2006
Database last updated on 13.09.2024
Most recent event   Tooltip14.07.2006Application deemed to be withdrawnpublished on 16.08.2006  [2006/33]
Applicant(s)For all designated states
Prionics AG
Waigstrasse 27a
CH-8952 Schlieren / CH
[2004/35]
Inventor(s)01 / Frigg, Rico
Weite Gasse 5
8001 Zürich / CH
 [2004/35]
Representative(s)Emmel, Thomas
Schaefer Emmel Hausfeld
Patentanwälte
Krohnstieg 43
22415 Hamburg / DE
[N/P]
Former [2004/35]Emmel, Thomas, Dipl.-Biol., Dr.
Schaefer & Emmel, Gehölzweg 20
22043 Hamburg / DE
Application number, filing date03003375.714.02.2003
[2004/35]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1449536
Date:25.08.2004
Language:EN
[2004/35]
Search report(s)(Supplementary) European search report - dispatched on:EP01.04.2003
ClassificationIPC:A61K38/17, A61P27/00, A61P25/28, A61P9/10, A61P17/02
[2004/35]
CPC:
A61K38/16 (EP); A61P17/02 (EP); A61P25/28 (EP);
A61P27/00 (EP); A61P9/10 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/35]
TitleGerman:Prioproteine als therapeutische mittel zur behandlung von AP-1 assoziierten krankheiten[2004/35]
English:Prion proteins (PrP) as therapeutic agents for the treatment of AP-1 associated diseases[2004/35]
French:Protéines prions comme agents thérapeutiques pour le traitement de maladies associées à AP-1[2004/35]
Examination procedure17.02.2005Examination requested  [2005/16]
11.10.2005Despatch of a communication from the examining division (Time limit: M04)
22.02.2006Application deemed to be withdrawn, date of legal effect  [2006/33]
30.03.2006Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2006/33]
Fees paidRenewal fee
24.02.2005Renewal fee patent year 03
Penalty fee
Additional fee for renewal fee
28.02.200604   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US6379905  (FISHLEIGH ROBERT VINCENT [GB], et al) [X] 1-6,8-10,12-16 * column 2, line 45 - line 49 ** column 13, line 47 - column 14, line 14 *;
 [DX]WO0249662  (UNIV MCGILL [CA], et al) [DX] 1-16 * page 2, line 18 - line 21 * * page 3, line 1 - line 12 * * abstract *;
 [X]EP1251138  (SCHAETZL HERMANN DR [DE]) [X] 1-6,8-10,12-16 * paragraph [0005] - paragraph [0007] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.